Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Epigenetics Could Lead to Better Cancer Diagnosis

26.02.2007
DNA methylation is an epigenetic process that occurs when a methyl group binds to one of DNA’s four bases, cytosine. These changes are responsible for controlling the activity of genes by turning them off.

DNA methylation patterns differ dramatically between healthy and diseased tissue and thereby can serve as biomarkers, opening a window into earlier detection of disease. In a special issue of the journal Disease Markers published in February 2007, ten articles explore the details and challenges of cancer epigenetics.

Writing in the editorial, Guest Editor Martin Widschwendter (Institute for Women’s Health, University College London) emphasizes that, “The concept of early detection of tumours before they spread and become incurable, represents one of the most important challenges in reducing the impact of the growing burden of cancer worldwide…Altered patterns of DNA methylation can be detected with high sensitivity, potentially providing us with diagnostic, prognostic and predictive information, and can be reversed by appropriate drug treatment. These possibilities make cancer epigenetics a most exciting field of current translational research.”

Four articles document different epigenetic alterations in lung, prostate, ovarian and colorectal cancer. The observation of abnormal methylation in the RASSF1A gene in a broad spectrum of tumors is reviewed by Luke B. Hesson, Wendy N.Cooper and Farida Latif. Heidi Fiegl and Karim Elmasry review how DNA-methylation can form the basis for diagnostics and therapeutic monitors.

... more about:
»DNA »DNA methylation »epigenetic »methylation

Epigenetic silencing of the MGMT gene encoding a DNA repair enzyme was recently found to be of predictive value in a randomised clinical trial for newly diagnosed glioblastoma, reviewed by Peter Hau, Roger Stupp and Monika E. Hegi. The possibility of using epigenetic changes in normal tissue to predict an individuals risk of developing cancer is reviewed by Hengmi Cui.

Biostatisticians Todd A. Alonzo and Kimberly D. Siegmund provide an excellent review about various statistical approaches to analysis of the wealth of information gained by DNA methylation studies.

Finally, Craig A. Cooney discusses the recent emergence of “epigenetic epidemiology” where the causes of DNA methylations might be understood and used to direct epigenetics toward improved health and longevity.

Epigenetic Markers
Special issue of Disease Markers, Volume 23, Issues 1-2
Guest Editor: Martin Widschwendter
Table of Contents
EDITORIAL
5-methylcytosine – the fifth base of DNA: The fifth wheel on a car or a highly promising diagnostic and therapeutic target in cancer?

Martin Widschwendter

The Role of DNA Methylation in the Development and Progression of Lung Adenocarcinoma

Keith M. Kerr, Janice S. Galler, Jeffrey A. Hagen, Peter W. Laird, and Ite A. Laird-Offringa

Epigenetic markers for molecular detection of prostate cancer
Vera L. Costa, Rui Henrique & Carmen Jerónimo
Epigenetic Markers and Response to Chemotherapy in Cancer
Gordon Strathdee
DNA Methylation in Colorectal Cancer – impact on screening and therapy monitoring modalities ?

Marion Zitt, Matthias Zitt and Hannes M. Müller

The role of Rassf1a methylation in cancer
Luke B. Hesson, Wendy N.Cooper and Farida Latif
Cancer diagnosis, risk assessment and prediction of therapeutic response by means of DNA methylation markers

Heidi Fiegl and Karim Elmasry

MGMT methylation status : the advent of stratified therapy in glioblastoma?
Peter Hau, Roger Stupp, and Monika E. Hegi
Loss of imprinting of IGF2 as an epigenetic marker for the risk of human cancer
Hengmi Cui
Statistical methods for evaluating DNA methylation as a marker for early detection or prognosis

Todd A. Alonzo and Kimberly D. Siegmund

Epigenetics – DNA-Based Mirror of Our Environment?
Craig A. Cooney

Astrid Engelen | alfa
Further information:
http://www.iospress.nl

Further reports about: DNA DNA methylation epigenetic methylation

More articles from Life Sciences:

nachricht The balancing act: An enzyme that links endocytosis to membrane recycling
07.12.2016 | National Centre for Biological Sciences

nachricht Transforming plant cells from generalists to specialists
07.12.2016 | Duke University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

NTU scientists build new ultrasound device using 3-D printing technology

07.12.2016 | Health and Medicine

The balancing act: An enzyme that links endocytosis to membrane recycling

07.12.2016 | Life Sciences

How to turn white fat brown

07.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>